ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2026
A novel small molecule KMU-11361 attenuates rheumatoid arthritis by mechanistic inhibition of the TAK1-NF-κB-NLRP3 axis.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundRheumatoid arthritis (RA) is characterized by chronic inflammation and joint destructioncaused by dysregulated immune signaling. Despite the development of various protein kinaseinhibitors to treat inflammatory diseases such as RA, the results achieved are still notsatisfactory. PURPOSE: This study aimed to investigate the therapeutic potential and biological mechanisms of KMU-11361, an innovative multi-protein kinase inhibitor which modulates the inflammatorypathways involved in the pathophysiology of RA, using both in vitro and in vivo models ofarthritis.
methodsWe investigated the effects of KMU-11361 on lipopolysaccharide (LPS)-inducedinflammation, receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation,and osteoblast differentiation, using various assays in human rheumatoid arthritis (RA)-fibroblast-like synoviocytes (RA-FLS), THP-1 cells, RAW264.7 cells, T cells, and MC-3T3-E1 cells. Furthermore, we evaluated the toxicity and efficacy of KMU-11361 in a zebrafishmodel and a K/BxN serum transfer-induced arthritis mouse model. In addition, we performedkinase profiling and conducted molecular docking simulations to examine whether KMU-11361 interacts with MAPK1 and TAK1 involved in TLR4 signaling.
resultsKinase profiling and molecular docking analyses revealed that KMU-11361 interacts with MAPK1 and TAK1, key regulators of TLR4 signaling. KMU-11361 markedly suppressedTLR4-mediated inflammatory signaling by reducing LPS-induced pro-inflammatory cytokineproduction, phosphorylation of TAK1 and MAPKs, NF-κB activation, and NLRP3 expressionin RA-FLS and THP-1 cells. Additionally, KMU-11361 inhibited RANKL-inducedosteoclastogenesis in RAW264.7 cells and attenuated T-cell activation-associated signalingpathways. Notably, KMU-11361 promoted osteoblastic differentiation in MC3T3-E1 cells. Inthe K/BxN serum transfer-induced arthritis mouse model, KMU-11361 significantly reducedankle swelling and IL-6 levels.
conclusionKMU-11361 exhibits potent anti-inflammatory and bone-protective properties by targeting keykinases involved in TLR4-mediated signaling and osteoclast differentiation. These findingsprovide mechanistic insight into its biological activity and highlight its therapeutic potential inboth in vitro and in vivo models of arthritis.
Indexed as
Identifiers
41843120What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.